Article
The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease.
European journal of clinical pharmacology - 1 Feb 2009
Sun Yan-Ming, Wang Lan-Feng, Li Jia, Li Zhu-Qin, Pan Wei
Abstract excerpt
OBJECTIVE: To investigate whether leptin receptor (LEPR) 223A>G polymorphism influences serum lipid levels and whether this polymorphism affects the effectiveness of simvastatin in Chinese patients with coronary heart disease (CHD). METHODS: A total of 312 patients with CHD were treated with simvastatin 20 mg/day. Fasting serum lipids were determined before and after 12 weeks of treatment. RESULTS: Patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
